Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS - 25/11/20
Abstract |
Introduction |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging viral pathogen that causes the novel coronavirus disease of 2019 (COVID-19) and may result in hypoxemic respiratory failure necessitating invasive mechanical ventilation in the most severe cases.
Objective |
This narrative review provides evidence-based recommendations for the treatment of COVID-19 related respiratory failure requiring invasive mechanical ventilation.
Discussion |
In severe cases, COVID-19 leads to hypoxemic respiratory failure that may meet criteria for acute respiratory distress syndrome (ARDS). The mainstay of treatment for ARDS includes a lung protective ventilation strategy with low tidal volumes (4–8 mL/kg predicted body weight), adequate positive end-expiratory pressure (PEEP), and maintaining a plateau pressure of < 30 cm H2O. While further COVID-19 specific studies are needed, current management should focus on supportive care, preventing further lung injury from mechanical ventilation, and treating the underlying cause.
Conclusions |
This review provides evidence-based recommendations for the treatment of COVID-19 related respiratory failure requiring invasive mechanical ventilation.
Le texte complet de cet article est disponible en PDF.Keywords : SARS-CoV-2, COVID-19, Acute respiratory distress syndrome, Respiratory failure, Lung protective strategy, Mechanical ventilation
Plan
Vol 38 - N° 10
P. 2194-2202 - octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.